tracking
John Talley Turns His Attention to Cancer Therapy

John Talley Turns His Attention to Cancer Therapy

For Euclises, it’s simple. Without the work of John Talley, Ph.D., the world would not have Celebrex®, the blockbuster arthritis treatment that has generated in excess of $3.5 billion in sales for Pfizer. Or Dynastat®, an injectable COX-2 inhibitor that’s sold in... Read more

A Q&A session with Euclises’ John Talley

[iSelect] You have the honorable position of being one of the leading medicinal chemists in the world. [John] It’s funny.  I don’t think of myself that way at all.  I’ve had the great fortune to work with really great people on really good projects. We worked on some... Read more